The Role of Intestinal Microbiota Dysbiosis in the Development of Spondyloarthritis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Role of Intestinal Microbiota Dysbiosis in the Development of Spondyloarthritis — Stella

Home/Spondyloarthritis/

View on ClinicalTrials.gov

Recruiting

Back to Spondyloarthritis trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

France

Service de Rhumatologie, Hôpital Ambroise Paré, APHP, Boulogne-Billancourt

Key details

Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment target

~100 participants

Started

June 2021

Primary completion

May 2026

Age range

18 Years and older

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.